Journal for ImmunoTherapy of Cancer (Nov 2020)

40 The orion™ platform from rarecyte® enables same-day 21-plex fluorescence tissue analysis

Daniel Campton,
Jeremy Cooper,
Steven Reese,
Kyla Teplitz,
Jeffrey Werbin,
Joshua Nordberg,
Eric Kaldjian,
Tad George

Affiliations

Daniel Campton: RarCyte, Seattle, WA, USA
Jeremy Cooper: RarCyte, Seattle, WA, USA
Steven Reese: RarCyte, Seattle, WA, USA
Kyla Teplitz: RarCyte, Seattle, WA, USA
Jeffrey Werbin: RarCyte, Seattle, WA, USA
Joshua Nordberg: RarCyte, Seattle, WA, USA
Eric Kaldjian: RarCyte, Seattle, WA, USA
Tad George: RarCyte, Seattle, WA, USA

DOI: https://doi.org/10.1136/jitc-2020-SITC2020.0040
Journal volume & issue: Vol. 8, no. Suppl 3

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal